Location: Del Mar, CA
CIK: 0001993440 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $895M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ELVN | ENLIVEN THERAPEUTICS INC | 623,839 | $24.45M | 2.7% | $25.60 | 0.0% | COM | 29337E102 |
| CELC | CELCUITY INC | 210,578 | $24.04M | 2.7% | $107.47 | 0.0% | COM | 15102K100 |
| DNTH | DIANTHUS THERAPEUTICS INC | 220,921 | $18.54M | 2.1% | $47.58 | 0.0% | COM | 252828108 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 148,093 | $18.46M | 2.1% | $91.38 | 0.0% | COM | 697947109 |
| ERAS | ERASCA INC | 867,639 | $14.04M | 1.6% | $10.02 | 0.0% | COM | 29479A108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP DEL | 104,726 (+64.7%) | $62.1M (+100.5%) | 6.9% | $392.94 | +22.3% | COM | 91307C102 |
| APGE | APOGEE THERAPEUTICS INC | 513,770 (+8.2%) | $43.24M (+20.7%) | 4.8% | $49.95 | +44.6% | COM | 03770N101 |
| COGT | COGENT BIOSCIENCES INC | 947,339 (+14.9%) | $36.46M (+24.5%) | 4.1% | $29.31 | +27.5% | COM | 19240Q201 |
| BBIO | BRIDGEBIO PHARMA INC | 695,718 (+16.8%) | $51.66M (+13.4%) | 5.8% | $36.28 | +105.3% | COM | 10806X102 |
| KYMR | KYMERA THERAPEUTICS INC | 254,672 (+23.4%) | $21.21M (+32.0%) | 2.4% | $51.25 | +51.4% | COM | 501575104 |
| FULC | FULCRUM THERAPEUTICS INC | 2,256,109 (+19.2%) | $17.3M (-19.2%) | 1.9% | $10.21 | +1.6% | COM | 359616109 |
| IDYA | IDEAYA BIOSCIENCES INC | 873,838 (+20.8%) | $29.12M (+16.4%) | 3.3% | $32.22 | +5.1% | COM | 45166A102 |
| OLMA | OLEMA PHARMACEUTICALS INC | 768,662 (+24.4%) | $11.46M (-25.8%) | 1.3% | $19.30 | +31.9% | COM | 68062P106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 911,337 (+32.0%) | $17.83M (-17.0%) | 2.0% | $28.25 | +9.2% | COM | 92790C104 |
| PRAX | PRAXIS PRECISION MEDICINES I | 42,441 (+18.7%) | $13.67M (+29.8%) | 1.5% | $206.03 | +51.3% | COM NEW | 74006W207 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 315,563 (+20.1%) | $5.882M (+69.9%) | 0.7% | $46.07 | -65.2% | CLASS A ORD | 61559X104 |
| QURE | UNIQURE NV | 615,489 (+91.4%) | $10.06M (+30.7%) | 1.1% | $31.41 | -25.0% | SHS | N90064101 |
| ABVX | ABIVAX SA | 465,869 (+22.2%) | $51.87M (+0.9%) | 5.8% | $99.29 | — | SPONSORED ADS | 00370M103 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| GH | GUARDANT HEALTH INC | 271,685 | $27.75M | 3.1% | $89.46 | +20.1% | — | 40131M109 |
| ARGX | ARGENX SE | 23,256 | $19.56M | 2.2% | $388.36 | — | — | 04016X101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 146,303 | $15.66M | 1.7% | $106.08 | -3.1% | — | 76243J105 |
| RCUS | ARCUS BIOSCIENCES INC | 565,142 | $13.47M | 1.5% | $20.40 | +4.3% | — | 03969F109 |
| IRON | DISC MEDICINE INC | 153,206 | $12.17M | 1.4% | $50.06 | +47.9% | — | 254604101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TERN | TERNS PHARMACEUTICALS INC | 326,694 (-62.5%) | $17.22M (-51.1%) | 1.9% | $23.11 | +62.1% | COM | 880881107 |
| VERA | VERA THERAPEUTICS INC | 422,023 (-29.9%) | $16.98M (-44.3%) | 1.9% | $35.71 | +25.9% | CL A | 92337R101 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 558,336 (-37.5%) | $17.87M (-43.0%) | 2.0% | $23.08 | +46.2% | ORDINARY SHARES | N62509109 |
| ASND | ASCENDIS PHARMA A/S | 76,300 (-42.1%) | $17.45M (-37.9%) | 1.9% | $144.94 | — | SPONSORED ADR | 04351P101 |
| XENE | XENON PHARMACEUTICALS INC | 786,844 (-1.6%) | $45.75M (+27.6%) | 5.1% | $37.92 | +10.7% | COM | 98420N105 |
| AXSM | AXSOME THERAPEUTICS INC. | 188,772 (-8.8%) | $31.91M (-15.6%) | 3.6% | $94.05 | +91.7% | COM | 05464T104 |
| INSM | INSMED INC | 248,475 (-6.0%) | $40.63M (-11.7%) | 4.5% | $48.11 | +230.6% | COM PAR $.01 | 457669307 |
| RVMD | REVOLUTION MEDICINES INC | 468,376 (-26.6%) | $45.55M (-10.4%) | 5.1% | $45.05 | +128.7% | COM | 76155X100 |
| CYTK | CYTOKINETICS INC | 283,700 (-12.9%) | $18.7M (-9.6%) | 2.1% | $45.77 | +40.8% | COM NEW | 23282W605 |
| SRRK | SCHOLAR ROCK HLDG CORP | 446,390 (-2.9%) | $21.94M (+8.4%) | 2.5% | $37.51 | +21.2% | COM | 80706P103 |
| MIRM | MIRUM PHARMACEUTICALS INC | 400,464 (-16.8%) | $36.99M (-2.7%) | 4.1% | $33.08 | +191.9% | COM | 604749101 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ORIC | ORIC PHARMACEUTICALS INC | 2,017,284 | $25.56M | 2.9% | $10.42 | +3.4% | COM | 68622P109 |
| ROIV | ROIVANT SCIENCES LTD | 1,190,118 | $32.97M | 3.7% | $13.79 | +75.3% | SHS | G76279101 |
| NTRA | NATERA INC | 81,077 | $16.21M | 1.8% | $128.20 | +76.2% | COM | 632307104 |
| NUVL | NUVALENT INC | 370,344 | $37.94M | 4.2% | $71.10 | +45.8% | COM | 670703107 |